Withings, a leading digital health company, has announced the launch of its groundbreaking device, BeamO “multiscope,” which combines the functionalities of four health check devices into one. The device integrates thermometer, electrocardiogram (ECG), oximeter, and stethoscope capabilities, allowing individuals to perform comprehensive health checkups in the comfort of their own homes.
BeamO aims to revolutionize the field of telemedicine by enabling individuals to conduct a wider range of health tests at home and communicate with healthcare professionals through remote consultations. Unlike traditional home health scans that only measure temperature, BeamO provides a holistic approach to monitoring health, including heart and lung health assessments.
Advancing Telemedicine Efficiency
“BeamO is a transformative multiscope device. Once, body temperature was the only health scan routinely taken at home,” said Eric Carreel, president of Withings. “BeamO will revolutionize the measurement of the core vitals carried out during medical visits from the comfort of one’s own home.”
The device enables individuals to assess their core health vitals every day, providing a comprehensive overview of overall health and identifying potential areas of concern. By replacing single-purpose devices with the all-in-one BeamO, telemedicine becomes more efficient and effective for both patients and healthcare professionals.
Feature Highlights
BeamO is packed with advanced features that make it a powerful tool for regular health monitoring. Some of its key features include:
- ECG: BeamO combines traditional thermometer functionality with a 1-lead ECG, allowing users to measure heart rate and detect possible cardiovascular issues, including atrial fibrillation.
- Oximeter: The device also includes a blood oxygenation (SpO2) sensor, providing real-time readings of blood oxygen levels.
- Stethoscope: BeamO captures acoustic sound waves from the chest or back, allowing users to measure heart and lung function accurately.
- Real-time Measurements: BeamO features an easy-to-read LED display that shows measurements in real-time, providing instant feedback to users.
Withings has truly reimagined the thermometer of the future with BeamO. This innovative device enables individuals and families to perform comprehensive health checkups at home, improving the quality of telehealth visits and empowering individuals to take control of their own health.
“Post-pandemic telemedicine is commonplace. While convenient and cost-effective, remote visits lacked the ability for health professionals to carry out the routine checks they perform in person,” explained Eric Carreel. “BeamO will make this possible remotely with a device that combines the functionality of four different pieces of medical equipment.”
Withings is set to showcase BeamO at CES 2024, one of the largest tech trade shows in Las Vegas. The device will be available for purchase in the United States following FDA clearance. Retailing at $250, BeamO is expected to hit the market in June 2024.
“BeamO is a transformative multiscope device… This crucial data will provide a vital overview of overall health or warning signs of potential areas of concern… BeamO will be the thermometer of the future, providing the ability to assess temperature and observe the state of the heart and lungs.” – Eric Carreel, President of Withings
